RDF/XML JSON-LD N3/Turtle RDF/JSON
Author profile at the institutional portal

Colomer Bosch, Ramon ramon.colomer@uam.es

Medicina / Universidad Autónoma de Madrid

Publications

p53 expression in locally advanced pharyngeal squamous cell carcinoma

  • Lassaletta, L.
  • Brandáriz, J.A.
  • Benito, A.
  • De La Cruz, J.
  • Gómez, C.
  • Ballestín, C.
  • Hitt, R.
  • Colomer, R.
  • Álvarez-Vicent, J.J.
... View more Collapse

Archives Of Otolaryngology–head & Neck Surgery (p. 1356-1359) - 1/1/1999

Editor: American Medical Association

10.1001/archotol.125.12.1356 View at source

  • ISSN/ISBN 0886-4470

Oral vinorelbine in metastatic breast cancer

  • PF Conte
  • S Giovannelli

BREAST CANCER RESEARCH (p. S25-S25) - 1/1/2005

  • ISSN 14655411
  • iMarina

Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin (TM)) in HER2-overexpressing breast cancer cells

  • Javier A Menendez
  • Alejandro Vazquez-Martin
  • Ramon Colomer
  • Joan Brunet
  • Alegria Carrasco-Pancorbo
  • Rocio Garcia-Villalba
  • Alberto Fernandez-Gutierrez
  • Antonio Segura-Carretero
... View more Collapse

Bmc Cancer (p. 80-80) - 9/5/2007

10.1186/1471-2407-7-80

  • ISSN 14712407
  • iMarina

High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial

  • Perez-Gracia, JL
  • Colomer, R
  • Ruiz-Casado, A
  • Arcediano, A
  • Tornamira, MV
  • Gomez-Martin, C
  • Valentin, V
  • Mendiola, C
  • Cortes-Funes, H
  • Hornedo, J;
... View more Collapse

Bone Marrow Transplantation (p. 117-123) - 1/1/2001

10.1038/sj.bmt.1702751 View at source

  • ISSN 02683369

Breast cancer survivorship symptom management: current perspective and future development

  • G Van Londen
  • EB Beckjord
  • MA Dew
  • P Cuijpers
  • S Tadic
  • A Brufsky

Breast Cancer Management (p. 71-81) - 1/1/2013

  • iMarina

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

  • Quintela-Fandino M
  • Holgado E
  • Manso L
  • Morales S
  • Bermejo B
  • Colomer R
  • Apala JV
  • Blanco R
  • Muñoz M
  • Caleiras E
  • Iranzo V
  • Martinez M
  • Dominguez O
  • Hornedo J
  • Gonzalez-Cortijo L
  • Cortes J
  • Gasol Cudos A
  • Malon D
  • Lopez-Alonso A
  • Moreno-Ortíz MC
  • Mouron S
  • Mañes S
... View more Collapse

Breast Cancer Research - 1/12/2020

10.1186/s13058-020-01362-y View at source

  • ISSN 14655411

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

  • Mouron S, Manso L, Caleiras E, Rodriguez-Peralto JL, Rueda OM, Caldas C, Colomer R, Quintela-Fandino M, Bueno MJ

Breast Cancer Research (p. 21-21) - 1/12/2021

10.1186/s13058-021-01398-8

  • ISSN 14655411
  • iMarina

Nintedanib plus letrozole in early breast cancer: A phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

  • Quintela-Fandino M
  • Apala J
  • Malon D
  • Mouron S
  • Hornedo J
  • Gonzalez-Cortijo L
  • Colomer R
  • Guerra J
... View more Collapse

Breast Cancer Research - 24/5/2019

10.1186/s13058-019-1152-x View at source

  • ISSN 14655411

Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER-2/neu-overexpressing human breast cancer cells to docetaxel (taxotere)

  • Menendez, JA
  • Lupu, R
  • Colomer, R;

Breast Cancer Research And Treatment (p. 183-195) - 1/3/2004

10.1023/b:brea.0000018409.59448.60 View at source

  • ISSN 01676806

Real-world treatment in patients with HER2+metastatic breast cancer

  • Colomer, R.
  • Hall, P.
  • Szkultecka-Debek, M.
  • Bondi, R. C.
  • Flinois, A.
  • Auziere, S.
  • Le Cleac'h, J. Y.;
... View more Collapse

Breast Cancer Research And Treatment (p. 197-205) - 1/2/2018

10.1007/s10549-017-4567-z View at source

  • ISSN 01676806

Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …

  • Chau Dang
  • Michael S Ewer
  • Suzette Delaloge
  • Jean-Marc Ferrero
  • Mark Verrill
  • Ramon Colomer
  • Claudia Vieira
  • Luis de la Cruz Merino
  • Jennifer Lucas
  • Theresa L Werner
  • Hannah Douthwaite
  • Denise Bradley
  • Maeve Waldron-Lynch
  • Jennifer Eng-Wong
  • Sandra M Swain
... View more Collapse

1/1/2018

  • iMarina

Tratado de oncología

  • Hernán Cortés-Funes
  • Ramón Colomer Bosch
  • Emilio Alba Conejo

1/1/2009

  • ISBN 9788492620166
  • iMarina

Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  • J Rogado
  • MD Fenor De La Maza
  • V Pacheco-Barcia
  • JM Serra
  • P Toquero
  • B Vera
  • A Ballesteros
  • R Mondejar
  • O Donnay
  • B Obispo
  • R Colomer
  • JM Sanchez-Torres
... View more Collapse

1/1/2017

  • iMarina

Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study

  • J Albanell
  • E Ciruelos
  • R Colomer
  • J De la Haba
  • M Martin
  • De Salas-Cansado
  • B Munoz-Molina
  • C Tournier
  • P Thuresson
  • W Schleich
... View more Collapse

1/1/2015

  • iMarina

Medicina de precisión en oncología: Éxitos y perspectivas bioéticas

  • Ramón Colomer Bosch

Bioética Y Cáncer (p. 17-26) - 1/1/2020

  • iMarina

Fatty acid metabolism in cancer cell survival: A new anti-cancer target

  • Porta, Rut
  • Colomer, Ramon
  • Puig, Teresa;

Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011

  • iMarina

Tratamiento hormonal del cáncer

  • Ramón Colomer Bosch
  • M L Amador
  • J González Cortijo
  • MV Tornamira

Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003

  • iMarina

Her-2/neu-induced cytokine signature in breast cancer

  • Alejandro Vazquez-Martin
  • Ramon Colomer
  • Javier A Menendez

Advances In Experimental Medicine And Biology (p. 311-319) - 1/12/2008

10.1007/978-0-387-69080-3_29 View at source

  • ISSN 00652598

Gemcitabine- and taxane-based protocols in breast cancer [Protocoles à base de gemcitabine et taxanes dans le cancer du sein]

  • Colomer R

American Journal Of Cancer (p. 19-20) - 1/11/2004

10.2165/00024669-200403992-00009 View at source

  • ISSN 11756357

PROSPECTIVE TRANSGEICAM STUDY OF ONCOTYPE DX (R) IN CLINICAL DECISION MAKING IN ESTROGEN RECEPTOR-POSITIVE NODE-NEGATIVE BREAST CANCER WOMEN

  • Albanell, J.
  • Colomer, R.
  • Ruiz-Borrego, M.
  • Saenz, J. A. Garcia
  • Alba, E.
  • Martin, M.
  • Palacios, J.
  • Faull, I.
  • Corominas, J. M.
  • Lluch, A.;
... View more Collapse

Annals Of Oncology (p. 81-81) - 1/1/2010

  • ISSN 09237534
  • iMarina

Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy

  • Rogado, J.
  • Pozo, F.
  • Troule, K.
  • Sanchez-Torres, J. M.
  • Romero Laorden, N.
  • Mondejar Solis, R.
  • Donnay Candil, O.
  • Ballesteros Garcia, A. I.
  • Pacheco-Barcia, V.
  • Aspa, J.
  • Al-Shahrour, F.
  • Alfranca, A.
  • Colomer, R.;
... View more Collapse

Annals Of Oncology (p. S999-S1000) - 1/1/2021

10.1016/j.annonc.2021.08.1889 View at source

  • ISSN 09237534

Pertuzumab/trastuzumab in early stage HER2-positive breast cancer: 5-year and final analysis of the BERENICE trial

  • Dang, C.
  • Ewer, M. S.
  • Delaloge, S.
  • Ferrero, J-M.
  • Colomer, R.
  • de la Cruz Merino, L.
  • Dadswell, K.
  • Verrill, M.
  • Eiger, D.
  • Sarkar, S.
  • de Haas, S.
  • Restuccia, E.
  • Swain, S. M.;
... View more Collapse

Annals Of Oncology (p. S38-S39) - 1/5/2021

10.1016/j.annonc.2021.03.057 View at source

  • ISSN 09237534

Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival

  • V Pacheco-Barcia
  • T France
  • G Zogopoulos
  • N Bouganim
  • O Donnay
  • T Alcindor
  • R Mondéjar Solís
  • K Guo
  • E Martin
  • R Colomer
  • J Asselah
... View more Collapse

Annals Of Oncology (p. mdy151. 163-mdy151. 163) - 1/1/2018

  • ISSN 09237534
  • iMarina

Safety of self-expandable metal stents (SEMS) or emergency surgery for acute colonic obstruction in metastatic colon cancer patients treated with bevacizumab

  • Pacheco-Barcia, V.
  • Mondejar Solis, R.
  • Martinez Saez, O.
  • Longo Munoz, F.
  • Bermejo, E.
  • Moreno Monteagudo, J.
  • Marin, C.
  • Correa, A.
  • Maqueda, R.
  • Rogado, J.
  • Garcia de Paredes, A.
  • Rodriguez de Santiago, E.
  • Pachon Olmos, V.
  • Ferreiro Monteagudo, R.
  • Rodriguez Garrote, M.
  • Carrato, A.
  • Donnay, O.
  • Martin, E.
  • Santander, C.
  • Colomer, R.;
... View more Collapse

Annals Of Oncology - 1/1/2018

  • ISSN 09237534
  • iMarina

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study

  • Im, S-A.
  • Tan, A. R.
  • Mattar, A.
  • Colomer, R.
  • Stroyakovskii, D.
  • Nowecki, Z.
  • De Laurentiis, M.
  • Pierga, J-Y.
  • Jung, K. H.
  • Schem, C.
  • Aguila, C.
  • Crnjevic, T. Badovinac
  • Heeson, S.
  • Shivhare, M.
  • Alexandrou, A.
  • Restuccia, E.
  • Jackisch, C.;
... View more Collapse

Annals Of Oncology (p. S40-S41) - 1/5/2021

10.1016/j.annonc.2021.03.060 View at source

  • ISSN 09237534

The impact of primary tumor location in patients with resected colorectal liver metastasis

  • Pacheco-Barcia, V.
  • Donnay, O.
  • Solis, R. Mondejar
  • Serrano, R.
  • Martin, E.
  • del Campo, L.
  • Rogado, J.
  • Vera, B.
  • Ballesteros, A.
  • Colomer, R.;
... View more Collapse

Annals Of Oncology - 1/1/2018

  • ISSN 09237534
  • iMarina

Could a systemic inflammation response index (SIRI) predict overall survival (OS) in metastatic pancreatic cancer (PC)?

  • Pacheco-Barcia, V.
  • Donnay, O.
  • Mondejar, R.
  • Rogado, J.
  • Fenor de la Maza, M. D.
  • Colomer, R.;

Annals Of Oncology - 1/1/2017

  • ISSN 09237534
  • iMarina

[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]

  • Sanchez-Munoz, A
  • Gravalos Castro, C
  • Colomer Bosch, R
  • Garcia Velasco, A
  • Garcia, J P
  • Cortes-Funes, H

Revista Clinica Espanola (p. 597-598) - 1/1/2003

10.1157/13053731

  • ISSN 15781860
  • iMarina

A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer

  • Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R

Clinical Breast Cancer (p. 286-91) - 1/1/2003

10.3816/cbc.2003.n.034 View at source

  • ISSN 15268209

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

  • Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators

Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020

10.1200/jco.20.02514

  • ISSN 0732183X
  • iMarina

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

  • Arranz, R.
  • García-Alfonso, P.
  • Sobrino, P.
  • Zamora, P.
  • Carrión, R.
  • García-Laraña, J.
  • Pérez, G.
  • López, J.
  • Lavilla, E.
  • Lozano, M.
  • Rayón, C.
  • Colomer, R.
  • González Barón, M.
  • Flores, E.
  • Pérez-Manga, G.
  • Fernández-Rañada, J.M.
... View more Collapse

Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998

Editor: American Society of Clinical Oncology

10.1200/jco.1998.16.4.1538 View at source

  • ISSN 0732183X
  • ISSN/ISBN 0732-183X

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

  • Hitt, R
  • Paz-Ares, L
  • Hidalgo, M
  • Colomer, R
  • Brandariz, A
  • Pena, M
  • Alvarez-Vicent, J
  • Hornedo, J
  • Cortes-Funes, H;
... View more Collapse

Seminars In Oncology (p. S19-20) - 1/12/1997

  • ISSN 00937754
  • iMarina

Desestabilización estructural de la adicción a oncogenes en cáncer de mama mediante el bloqueo de la sintasa de ácidos grasos

  • Colomer Bosch, Ramon (Investigador principal (IP))

Period: 01-01-2012 - 31-12-2014

  • iMarina

Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas

  • Rebeca Mondéjar Solís (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia

28/1/2021

  • iMarina

Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís

1/1/2016

  • iMarina

El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Javier Abel Menéndez Menéndez (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo

1/1/2016

  • iMarina

Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín

1/1/2007

  • iMarina

Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia

1/1/2004

  • iMarina

Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo

1/1/2003

  • iMarina

Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz

1/1/2002

  • iMarina

Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez

1/1/2001

  • iMarina

Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater

1/1/1996

  • iMarina

This researcher has no patents or software licenses.

Last data update: 4/24/24 1:20 PM